Table 2. Univariate Analysis and Multivariate Analysis of Correlations among Clinicopathological Parameters and Survival Time of Patients with Gastric Cancer.
| Variable | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI for HR | p | HR | 95% CI for HR | p | |
| Gender | ||||||
| Male vs. female | 0.827 | 0.405–1.685 | 0.600 | |||
| Age | ||||||
| ≤65 vs. >65 | 0.886 | 0.525–1.496 | 0.651 | |||
| Tumor size (cm) | ||||||
| <5 vs. ≥5 | 0.924 | 0.546–1.565 | 0.769 | |||
| Depth of invasion | ||||||
| T1–T2 vs. T3–T4 | 3.417 | 1.543–7.566 | 0.002 | 2.547 | 0.964–6.728 | 0.059 |
| Differentiation | ||||||
| Well and moderate vs. poorly and not | 1.745 | 1.036–2.940 | 0.036 | 1.324 | 0.748–2.343 | 0.335 |
| Stages | ||||||
| I–II vs. III–IV | 2.572 | 1.506–4.393 | 0.001 | 0.937 | 0.159–5.535 | 0.943 |
| Lymph node metastases | ||||||
| 0 vs. ≥1 | 2.182 | 1.269–3.753 | 0.005 | 1.631 | 0.303–8.783 | 0.569 |
| Distant metastasis | ||||||
| Present vs. absent | 4.274 | 1.769–10.325 | 0.001 | 2.593 | 1.038–6.475 | 0.041 |
| miR-191 expression | ||||||
| Low vs. high | 3.449 | 1.900–6.260 | <0.001 | 2.245 | 1.143–4.410 | 0.019 |
miR-191, microRNA-191; CI, confidence interval; HR, hazard ratio.